Salmonella, Measles, and Ebola Updates Lead Health Roundup
MedPage Today’s roundup covers an oyster-linked Salmonella outbreak, a third measles death in Pennsylvania, and Ebola cases in Nigeria and Kenya.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
TMVR System Recall and Cannabis Paradox Highlight Cardiology News
Recent cardiovascular developments include a device recall, a paradoxical cannabis finding, and new evidence on rapid troponin testing.
OpenEvidence and Doximity Settle AI Trade-Secret Lawsuit
The settlement ends a bitter dispute over alleged doctor impersonation and corporate espionage, leaving both clinical AI rivals to compete without legal distraction.
Inhaled Exosome Therapy Shows Promise for ARDS in Phase IIb Trial
An investigational inhaled exosome-based drug helped more ARDS patients recover from respiratory failure and reduced mortality in a mid-stage trial.
New drug launch prices: median net price rises to $257,000
Inflation-adjusted launch prices for new medicines remain high, with about one in four drugs priced above $500,000.
Lawmakers urge FDA to close peptide regulatory loophole
A bipartisan group in Congress is pressing the FDA to tighten oversight of peptides, a policy area tied to obesity drugs.
Rapport's epilepsy drug succeeds in bipolar mania trial
An experimental epilepsy pill from Rapport Therapeutics narrowly met its main goal in a mid-stage bipolar mania study, opening a path to a potential billion-dollar market.
Long-Term MINT Data Show Sustained Benefit of Inebilizumab in Myasthenia Gravis
One-year open-label follow-up from the phase III MINT trial shows inebilizumab's benefits in generalized myasthenia gravis persist and may deepen over time.
Three-Year Wait for Intestine Shows Transplant System's Hidden Complexity
A rare intestine transplant patient's long wait reveals how opaque hospital and organ procurement policies can waste viable organs and disadvantage patients.
Proposed ACGME rule changes could weaken resident shift protections
An opinion piece argues that the ACGME's proposed changes to resident work-hour rules would reduce mandatory rest and increase burnout risk.
Billion-dollar bets on PD-(L)1/VEGF drugs outpace clinical proof
A new analysis finds drugmakers are paying enormous sums for oncology platforms before randomized evidence settles whether they work.
Paying for Cures: A Radical Fix for Cell and Gene Therapies
A new proposal argues that without new payment models, cell and gene therapy innovation will stall.
Nurse With Cancer Calls for Patient-Tested AI Health Information
A nurse and cancer patient argues that AI-generated patient materials must be tested by patients themselves, not just checked for medical accuracy.
FDA Approves First Generic of Weekly Estradiol-Levonorgestrel Patch
The approval gives postmenopausal women with an intact uterus a more affordable once-weekly option for managing hot flashes and preventing osteoporosis.
Midterms May Boost Vaccine Allies in Congress, but Threats Persist
Even a more pro-vaccine Congress in 2027 would leave immunization policy exposed to hostile executive-branch action, the authors argue.
Readily Raises $11M for Compliance Intelligence Platform
The Series A round, led by Define Ventures, will support Readily's compliance intelligence platform.
Jalen Hurts' Blood Clots: Risks and Recovery Outlook
Experts say the quarterback's deep vein thrombosis and pulmonary embolism are serious but treatable, with full recovery expected.
Opioids and Gabapentinoids Double Opioid Disorder Risk in Acute Back Pain
A large Medicaid study adds fresh evidence that nondrug therapies should be the first choice for acute low back pain.